Brief: Fujirebio Diagnostics Initiates Clinical Testing Of Automated Lumipulse SARS CoV-2 Antigen Assay

H.U. group

05/08/2020 13:04

Aug 5 (Reuters) - Fujirebio Diagnostics:
    * FUJIREBIO DIAGNOSTICS ANNOUNCES INITIATION OF CLINICAL
TESTING
FOR FULLY AUTOMATED LUMIPULSE® SARS COV-2 ANTIGEN ASSAY
    * FUJIREBIO DIAGNOSTICS - INITIAL SUBMISSION TO FDA IS
EXPECTED TO
BE MADE IN EARLY SEPTEMBER FOR NASOPHARYNGEAL SWAB IN UNIVERSAL
VIRAL TRANSPORT MEDIA

Source text for Eikon:  ID:nBw2Lq7xga 
Further company coverage:  4544.T 

 ((Reuters.Briefs@thomsonreuters.com;))